<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem. Biol.</journal-id>
<journal-title>Frontiers in Chemical Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem. Biol.</abbrev-journal-title>
<issn pub-type="epub">2813-530X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1620562</article-id>
<article-id pub-id-type="doi">10.3389/fchbi.2025.1620562</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemical Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Preliminary investigation of Ru(II) complexes bearing nile red chromophores for photodynamic therapy</article-title>
<alt-title alt-title-type="left-running-head">Condon et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchbi.2025.1620562">10.3389/fchbi.2025.1620562</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Condon</surname>
<given-names>Claire</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3163433/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Careta-Borr&#xe0;s</surname>
<given-names>Oriol</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fodor</surname>
<given-names>Judit</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3094608/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Al Riyami</surname>
<given-names>Amani B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3122429/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Xiao</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Jianzhang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/791175/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nogu&#xe9;s</surname>
<given-names>Carme</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3095591/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Draper</surname>
<given-names>Sylvia M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/763024/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Chemistry</institution>, <institution>Trinity College Dublin</institution>, <addr-line>Dublin</addr-line>, <country>Ireland</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Departament de Biologia Cellular</institution>, <institution>Fisiolog&#xed;a i Immunologia</institution>, <institution>Universitat Aut&#xf2;noma de Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>State Key Laboratory of Fine Chemicals</institution>, <institution>Dalian University of Technology</institution>, <addr-line>Dalian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/513095/overview">Roy Planalp</ext-link>, University of New Hampshire, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3085180/overview">Aakriti Garg</ext-link>, University of New Hampshire, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3113633/overview">Nir Hananya</ext-link>, Technion Israel Institute of Technology, Israel</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Sylvia M. Draper, <email>smdraper@tcd.ie</email>; Carme Nogu&#xe9;s, <email>carme.nogues@uab.cat</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>4</volume>
<elocation-id>1620562</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Condon, Careta-Borr&#xe0;s, Fodor, Al Riyami, Xiao, Zhao, Nogu&#xe9;s and Draper.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Condon, Careta-Borr&#xe0;s, Fodor, Al Riyami, Xiao, Zhao, Nogu&#xe9;s and Draper</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Two previously investigated Ru(II) triplet photosensitisers (PS) (<bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>) comprising a bipyridyl frame and acetylene appended Nile red chromophore, were converted to their chloride salts for cytotoxicity and phototoxicity measurements. SKBR3-cell lines were used to evaluate the photodynamic activity of the compounds. Irradiation (<inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mi mathvariant="bold-italic">&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 630&#xa0;nm; 15&#xa0;min; 33&#xa0;J&#xa0;cm<sup>&#x2212;2</sup>) at a non-toxic concentration of 10&#xa0;nM, <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> induced a reduction in metabolic activity by 60% and 30% respectively.</p>
</abstract>
<kwd-group>
<kwd>ruthenium</kwd>
<kwd>coordination chemistry</kwd>
<kwd>photobiology</kwd>
<kwd>SKBR-3 breast cancer cells</kwd>
<kwd>photodynamic therapy</kwd>
<kwd>Nile red</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Bioinorganic Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Our group previously reported efficient Ru(II) and Ir(III) triplet photosensitisers (PS) when functionalised with pyrene, BODIPY, carbazole, courmarin-6, and Nile red chromophores, in mono- and dinuclear complexes, and in multinuclear porphyrin-based compounds (<xref ref-type="bibr" rid="B6">Conway-Kenny et al., 2021</xref>; <xref ref-type="bibr" rid="B3">Cabrera-Gonz&#xe1;lez et al., 2019</xref>; <xref ref-type="bibr" rid="B7">Hallen et al., 2023</xref>; <xref ref-type="bibr" rid="B13">Lu et al., 2017</xref>; <xref ref-type="bibr" rid="B14">Lu et al., 2018</xref>; <xref ref-type="bibr" rid="B11">Lu et al., 2016a</xref>; <xref ref-type="bibr" rid="B20">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="B19">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="B12">Lu et al., 2016b</xref>). The purpose of this new work is to evaluate the PS efficiency of the Nile red systems more thoroughly and to explore whether their photophysical properties, which are determined by their structural and electronic features, change when tested in conditions more closely aligned to those used in Photodynamic Therapy (PDT) applications.</p>
<p>Transition metal (TM) polypyridyl compounds benefit from the heavy atom effect. This increases spin orbit coupling and leads to the greater intersystem crossing from the singlet to triplet state, so essential to PDT applications (<xref ref-type="bibr" rid="B9">Josefsen and Boyle, 2008</xref>). Metal-polypyridyl frameworks offer diversity and tunability of the photophysical properties; through changing the metal centre or ligand, extending the aromaticity/conjugation of the coordinating ligands and/or attaching chromophores. In particular, Ru(II) complexes often have favourable properties for PDT, such as low dark toxicity and biocompatibility (<xref ref-type="bibr" rid="B16">Mital and Ziora, 2018</xref>). TM complexes for PDT are widely explored in the literature (<xref ref-type="bibr" rid="B8">Huang et al., 2019</xref>; <xref ref-type="bibr" rid="B15">Mani et al., 2023</xref>; <xref ref-type="bibr" rid="B21">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="B10">Lazic et al., 2017</xref>; <xref ref-type="bibr" rid="B18">Parella et al., 2024</xref>), and TLD-1433, a Ru(II) PS, is currently in clinical trials as a photosensitiser for bladder cancer treatment (<xref ref-type="bibr" rid="B4">Chamberlain et al., 2020</xref>; <xref ref-type="bibr" rid="B17">Monro et al., 2019</xref>). Evaluating the features of the molecules from a modular approach to PS design, has potential benefits to a wide range of applications.</p>
<p>
<bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (<xref ref-type="fig" rid="F1">Figure 1</xref>) have a Ru(II) bipyridyl frame with an appended Nile red chromophore. The latter is connected to the complex by an acetylene linker, as is characteristic of our group&#x2019;s molecular design motif. The complexes were formed utilising an &#x2018;on the complex&#x2019; synthetic strategy involving Sonogashira coupling reaction (<xref ref-type="bibr" rid="B6">Conway-Kenny et al., 2021</xref>; <xref ref-type="bibr" rid="B3">Cabrera-Gonz&#xe1;lez et al., 2019</xref>; <xref ref-type="bibr" rid="B11">Lu et al., 2016a</xref>; <xref ref-type="bibr" rid="B5">Condon et al., 2021</xref>). Both compounds were shown to absorb strongly in the visible region, with the <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (&#x3b5;<sub>450/557 nm</sub> &#x3d; 11,900/33,500&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>) having reduced molar extinction coefficient compared to <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (&#x3b5;<sub>450/560 nm</sub> &#x3d; 12,600/47,300&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>). Both complexes have two weakly emissive states originating from an intraligand charge transfer, <sup>1</sup>ILCT&#x2a; (557/565&#xa0;nm), and a metal to ligand charge transfer, <sup>3</sup>MLCT&#x2a; (450&#xa0;nm) transition. A long lived, ILCT based, non-emissive triplet excited state was also identified (<inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 510&#xa0;nm, CH<sub>3</sub>CN, [10<sup>&#x2212;5</sup>&#xa0;M] <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>: <inline-formula id="inf3">
<mml:math id="m3">
<mml:mrow>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>T</sub> 101.4&#xa0;&#x3bc;s; <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>: <inline-formula id="inf4">
<mml:math id="m4">
<mml:mrow>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>T</sub> 266.8&#xa0;&#x3bc;s) that is capable of significant <sup>1</sup>O<sub>2</sub> generation (CH<sub>3</sub>CN, <inline-formula id="inf5">
<mml:math id="m5">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 534&#xa0;nm <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>: &#x3a6;<sub>&#x394;</sub> 42.3%; [<bold>Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>: &#x3a6;<sub>&#x394;</sub> 51.0%).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Structure of <bold>[Ru-2ENR]</bold>
<sup>
<bold>2&#x2b;</bold>
</sup> and <bold>[Ru-3ENR]</bold>
<sup>
<bold>2&#x2b;</bold>
</sup>.</p>
</caption>
<graphic xlink:href="fchbi-04-1620562-g001.tif">
<alt-text content-type="machine-generated">Chemical structures of two ruthenium complexes. The top complex is labeled [Ru-2ENR][(PF&#x2086;)&#x2082;]/[(Cl)&#x2082;], and the bottom complex is labeled [Ru-3ENR][(PF&#x2086;)&#x2082;]/[(Cl)&#x2082;]. Both structures feature a central ruthenium atom coordinated with ligands containing nitrogen, oxygen, and aromatic rings. The labels indicate a positive charge of two.</alt-text>
</graphic>
</fig>
<p>Further to our previous work on <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (<xref ref-type="bibr" rid="B5">Condon et al., 2021</xref>), recent computational reports by Scolotti and Mazzone et al. have used these two PF<sub>6</sub> Ru complexes as benchmarks for proposing, via computational analyses, new and analogous compounds for PDT (<xref ref-type="bibr" rid="B1">Barretta et al., 2024a</xref>; <xref ref-type="bibr" rid="B2">Barretta et al., 2024b</xref>). Their theoretical calculations were in good agreement with our own previously reported computational and photophysical studies. The lowest energy absorptions, assigned as ILCTs in the calculated spectra of <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> were at 561 and 571&#xa0;nm respectively (557 and 565&#xa0;nm experimentally). The triplet states reside on the chromophore in both compounds and are ILCT in origin. They are localised on the ethynyl-Nile red moiety for <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> but extend to include the pyridyl ring on the appended bpy in <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> as this is the more linear and conjugated of the two ligands.</p>
<p>Computationally determined rate constants of the intersystem crossing, k<sub>ISC</sub>, for the most plausible ISC process, indicated how well the complexes might populate their triplet excited states. While concluding that both complexes can generate <sup>1</sup>O<sub>2</sub>, <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> with the lower k<sub>ISC</sub>, was computationally predicted to have lower efficiency or lower singlet oxygen quantum yields (<xref ref-type="bibr" rid="B1">Barretta et al., 2024a</xref>; <xref ref-type="bibr" rid="B2">Barretta et al., 2024b</xref>).</p>
<p>Based on the experimental and computational photophysical results, we were encouraged to undertake a preliminary biological evaluation of these two PSs to experimentally determine their potential in solvents and conditions more aligned to those appropriate to photodynamic therapeutic agents and to compare our findings with those anticipated computationally.</p>
<p>Firstly, to further explore the two emissive excited states, nanosecond time-resolved absorption studies were carried out, exciting into the MLCT (450&#xa0;nm) and the ILCT bands (560&#xa0;nm) respectively (<xref ref-type="sec" rid="s10">Supplementary Figures S1, S2</xref>). Significant bleaching was observed at circa 560&#xa0;nm in both complexes due to the depletion of the ground state in the Nile red moiety when exciting at 450 or 560&#xa0;nm, with the longer wavelength causing considerably greater bleaching. The triplet excited lifetimes (<inline-formula id="inf6">
<mml:math id="m6">
<mml:mrow>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>T</sub>) at the bleaching peaks were 123.4/140.2&#xa0;&#x3bc;s for <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, (<xref ref-type="sec" rid="s10">Supplementary Figures S1b,d</xref>) and 206.0/234.7&#xa0;&#x3bc;s for <bold>[Ru-3ENR][(PF6)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (<xref ref-type="sec" rid="s10">Supplementary Figures S2b,d</xref>).</p>
<p>The &#x3a6;<sub>&#x394;</sub> measurements for the two <bold>[Ru(II)][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> complexes were repeated at a longer excitation wavelength of 610&#xa0;nm (<inline-formula id="inf7">
<mml:math id="m7">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> &#x3d; 534&#xa0;nm previously) in order to approach that of the biological window (650&#x2013;800&#xa0;nm) for PDT (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). The &#x3a6;<sub>&#x394;</sub> increased by circa 80% for both complexes when excited at a lower energy wavelength with <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> reaching 90%. The results of the new photophysical measurements are summarised in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Photophysical data of <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Complex</th>
<th align="center">
<inline-formula id="inf8">
<mml:math id="m8">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>abs</sub>
<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref> [nm]</th>
<th align="center">&#x3b5;<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>(M<sup>&#x2212;1</sup> cm<sup>&#x2212;1</sup>)</th>
<th align="center">
<inline-formula id="inf9">
<mml:math id="m9">
<mml:mrow>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>T</sub>
<xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref> (&#x3bc;s)</th>
<th align="center">
<inline-formula id="inf10">
<mml:math id="m10">
<mml:mrow>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>T</sub>
<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref> (&#x3bc;s)</th>
<th align="center">&#x3a6;<sub>&#x394;</sub>
<xref ref-type="table-fn" rid="Tfn4">
<sup>d</sup>
</xref> [%]</th>
<th align="center">&#x3a6;<sub>&#x394;</sub>
<xref ref-type="table-fn" rid="Tfn5">
<sup>e</sup>
</xref> [%]</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>
</td>
<td align="center">450/555</td>
<td align="center">11,900/33,500</td>
<td align="center">123.4</td>
<td align="center">140.2</td>
<td align="center">42.3</td>
<td align="center">77.2</td>
</tr>
<tr>
<td align="left">
<bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>
</td>
<td align="center">450/565</td>
<td align="center">12,600/47,300</td>
<td align="center">206.0</td>
<td align="center">234.7</td>
<td align="center">51.0</td>
<td align="center">90.4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>Absorption maxima and molar absorptivity in CH<sub>3</sub>CN [10<sub>-5</sub> M], 298 K. Triplet state lifetime in deaerated CH<sub>3</sub>CN excited at</p>
</fn>
<fn id="Tfn2">
<label>
<sup>b</sup>
</label>
<p>450&#xa0;nm and</p>
</fn>
<fn id="Tfn3">
<label>
<sup>c</sup>
</label>
<p>565&#xa0;nm. [10&#x2212;5&#xa0;M], 298&#xa0;K. Singlet oxygen quantum yields determined indirectly from the decay rate of DPBF at &#x3bb;<sub>abs</sub> with</p>
</fn>
<fn id="Tfn4">
<label>
<sup>d</sup>
</label>
<p>diiodobodipy as the standard (&#x3a6;<sub>D</sub> &#x3d; 83 &#x0025; in CH<sub>2</sub>Cl<sub>2</sub>) in CH<sub>3</sub>CN, l<sub>ex</sub> &#x3d; 534 nm,</p>
</fn>
<fn id="Tfn5">
<label>
<sup>e</sup>
</label>
<p>methylene blue as the standard (&#x3a6;<sub>D</sub> &#x3d; 57 &#x0025; in CH<sub>2</sub>Cl<sub>2</sub>) in CH<sub>3</sub>CN, l<sub>ex</sub> &#x3d; 610 nm.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>To improve the solubility of the complexes in aqueous media, their counterions were exchanged for chloride ions by passing them through a short silica column (CH<sub>3</sub>CN, H<sub>2</sub>O, KCl(aq), 100:10:1 v/v/v). Complete anion exchange was confirmed via <sup>35</sup>Cl and <sup>19</sup>F NMR spectra (<xref ref-type="sec" rid="s10">Supplementary Figures S4, S5</xref>). It was shown previously that the <sup>1</sup>ILCT absorption bands of the complexes were sensitive to the solvent environment and the absorption maxima red-shifted in methanol relative to the spectra in acetonitrile (MeCN) (<xref ref-type="bibr" rid="B5">Condon et al., 2021</xref>). The UV-Vis spectra of the chloride salts were therefore measured in MeCN, DMSO and water (<xref ref-type="fig" rid="F2">Figures 2a,b</xref>). As for the PF<sub>6</sub> salts, the ILCT absorption maxima for both Cl compounds are considerably affected showing positive solvatochromism, and significant red shifts in the more polar DMSO and water. Broadened red-shifted absorption bands can be indicative of increased molecular/solvent interactions and the substantial effect of the electronic environment confirms the charge transfer character of this transition. The wavelength of the MLCT absorption maxima are unaffected for <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and only slight variation is seen in the extinction coefficient of this band for <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>UV-visible absorption spectra of <bold>(a) [Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>] (b) [Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, in MeCN, DMSO and H<sub>2</sub>O: [10<sup>-6</sup>&#xa0;M], 298&#xa0;K. Overlaid UV-visible absorption spectra of <bold>(c) [Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>], Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<sup>
<bold>&#x2212;</bold>
</sup>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<sup>
<bold>&#x2212;</bold>
</sup>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> in acetonitrile and <bold>(d) [Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> in water at 298&#xa0;K.</p>
</caption>
<graphic xlink:href="fchbi-04-1620562-g002.tif">
<alt-text content-type="machine-generated">Graphs depicting absorption spectra of various ruthenium complexes in different solvents. Panels (a) and (b) show absorbance versus wavelength for MeCN, DMSO, and H&#x2082;O. Specific peaks are highlighted with wavelengths. Panels (c) and (d) show molar absorptivity with complex details and extinction coefficients. Inset illustrations depict chemical structures.</alt-text>
</graphic>
</fig>
<p>In water, the ILCT <inline-formula id="inf12">
<mml:math id="m12">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>max</sub> is extended further than 600&#xa0;nm, shifting by 53&#xa0;nm for <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and 47&#xa0;nm for <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (<xref ref-type="fig" rid="F2">Figure 2d</xref>). The broadened low energy absorption bands now extend to 700&#xa0;nm, allowing excitation into the desired window for biological applications (650&#x2013;800&#xa0;nm). The two Cl compounds in acetonitrile have significantly lower molar extinction coefficients (14,500 and 28,400&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>) compared to the PF<sub>6</sub> salts measured under the same conditions (<xref ref-type="fig" rid="F2">Figure 2c</xref>), representing a 57% and 40% reduction. However on changing the solvent from MeCN to water for the chloride salts, the molar extinction coefficients of the low energy absorption bands show little change (12,700 and 28,500&#xa0;M<sup>&#x2212;1</sup>&#xa0;cm<sup>&#x2212;1</sup>) suggesting that the light-harvesting ability of the chloride salts is not significantly affected by a change in solvent polarity.</p>
<p>Our preliminary biological evaluation began with an investigation of the dark toxicity of <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> using an Alamar Blue assay. This test primarily measures metabolic activity and specifically the redox activity of living cells, which reflects the activity of mitochondrial and cytosolic enzymes. It does not directly measure cell proliferation or growth, but is widely used as a proxy in the literature for cell viability and cytotoxicity due to its sensitivity to changes in cellular metabolic activity.</p>
<p>The dark toxicity of <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> was evaluated using the SKBR-3 cell line (a human breast cancer cell line) to find the concentration at which more than 80% of the cells remain active for the phototoxicity studies. The cells were incubated for 24&#xa0;h and tested with the Alamar Blue assay (24&#xa0;h). They were then incubated for another 48&#xa0;h and a second Alamar Blue assay was performed (72&#xa0;h) (<xref ref-type="sec" rid="s10">Supplementary Figure S6</xref>). The PSs needed to exhibit less than 20% dark toxicity after 72&#xa0;h incubation to test for phototoxicity. Between 0.1 and 10&#xa0;&#x3bc;M concentrations, the toxicity of the compounds was too high and exceeded the maximum 20% (<xref ref-type="fig" rid="F3">Figure 3</xref>; <xref ref-type="sec" rid="s10">Supplementary Figure S7</xref>). Over 80% cell viability was achieved at 0.01 and 0.05&#xa0;&#x3bc;M for <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and 0.01&#xa0;&#x3bc;M for <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> (<xref ref-type="fig" rid="F3">Figures 3a,b</xref>).The non-negligible dark toxicity at concentrations in excess of 0.05&#xa0;&#x3bc;M might be expected to limit the therapeutic application of the materials. To contextualise this information the phototoxicity selectivity indices based on metabolic read-outs from the Alamar Bue Assay are provided (<xref ref-type="sec" rid="s10">Supplementary Figure S8</xref>). The highest selectivity index (2.31) is seen for <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> at 52h and 0.05&#xa0;&#x3bc;M.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Dark toxicity. <bold>(a,b)</bold> Cell viability of SKBR-3 cells incubated in dark conditions with different concentrations of [<bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>],</bold> (0.01, 0.05, 0.1, 0.5 and 1&#xa0;&#xb5;M), and control (0&#xa0;&#xb5;M) at <bold>(a)</bold> 24&#xa0;h and <bold>(b)</bold> 72&#xa0;h. Photodynamic treatment effects after 15&#xa0;min irradiation <bold>(c,d)</bold>. Cell viability of SKBR-3 cells incubated without (control) or with 0.01 and 0.05&#xa0;&#xb5;M of <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and 0.01&#xa0;&#xb5;M of <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> for 4&#xa0;h followed by cell wash. Cell viability was determined immediately after incubation <bold>(c)</bold> (4&#xa0;h) either in dark conditions (not irradiated) or after 15&#xa0;min irradiation at <inline-formula id="inf13">
<mml:math id="m13">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 620&#x2013;630&#xa0;nm (irradiated) and <bold>(b)</bold> after further 48&#xa0;h in standard culture conditions (52&#xa0;h). Three independent experiments were performed for each set of conditions. Asterisks indicate statistically significant differences in the cell viability between the not irradiated control and product at each time-point and condition (p &#x3c; 0.05).</p>
</caption>
<graphic xlink:href="fchbi-04-1620562-g003.tif">
<alt-text content-type="machine-generated">Bar charts depict cell viability percentages under different conditions. Charts (a) and (b) show viability after 24 and 72 hours with varying Ru-2ENR and Ru-3ENR concentrations. Chart (c) compares viability with and without irradiation after 4 hours, while chart (d) compares the same after 52 hours. Control and experimental groups are indicated, with notable differences in viability at specific concentrations and treatments.</alt-text>
</graphic>
</fig>
<p>The phototoxicity of the complexes was tested by irradiating the cells after 4&#xa0;h incubation with the PSs, at &#x3bb;<sub>ex</sub> 630&#xa0;nm (33&#xa0;J&#xa0;cm<sup>&#x2212;2</sup>) for 15&#xa0;min. After irradiation, cell viability was tested immediately (4&#xa0;h, <xref ref-type="fig" rid="F3">Figure 3c</xref>). The cells were then incubated in the dark for 48&#xa0;h, after which time cell viability was tested again (52&#xa0;h, <xref ref-type="fig" rid="F3">Figure 3d</xref>). Immediately after irradiation (<xref ref-type="fig" rid="F3">Figure 3c</xref>), a decrease in cell survival was observed for both compounds. After 48&#xa0;h (<xref ref-type="fig" rid="F3">Figure 3d</xref>), a further decrease in cell viability was also observed. The <bold>3ENR</bold>-appended complex performed better than the <bold>2ENR</bold>. The <bold>3ENR</bold> appended complex showed an increase in &#x3a6;<sub>&#x394;</sub> compared to its <bold>2ENR</bold> analogue and had a significantly higher absorption coefficient (55%) in support of the enhanced photodynamic action seen for <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>.</p>
<p>The cellular uptake of the Cl complexes was evaluated by confocal microscopy, at a concentration of 10&#xa0;&#x3bc;M. The results are presented in <xref ref-type="fig" rid="F4">Figure 4</xref>. For both compounds, most of the PS remained attached to the plasma membrane, with a small amount of the product internalised.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Product internalisation. Live SKBR-3 cells incubated with 10&#xa0;&#xb5;M of <bold>(a)</bold> [<bold>Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, <bold>(b)</bold> [<bold>Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, for 4&#xa0;h and observed under confocal microscope. To analyse the localisation of the product, fluorescence mode was used. Product fluorescence emission was detected in the range of <inline-formula id="inf14">
<mml:math id="m14">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>em</sub> 580&#x2013;699&#xa0;nm by exciting the cells using a <inline-formula id="inf15">
<mml:math id="m15">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 488&#xa0;nm laser (15% of laser power). Wheat germ agglutinin (WGA) fluorescence emission (membrane) was detected in the range of <inline-formula id="inf16">
<mml:math id="m16">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>em</sub> 500&#x2013;530&#xa0;nm (green) by exciting the cells using a <inline-formula id="inf17">
<mml:math id="m17">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 488&#xa0;nm laser (12% of laser power). Maximum projection and orthogonal projection of z-stacks. Scale bar, 20&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fchbi-04-1620562-g004.tif">
<alt-text content-type="machine-generated">Microscopy images showing cellular structures treated with [Ru-2ENR][Cl]&#x2082; and [Ru-3ENR][Cl]&#x2082;. Each row contains four images: plasma membrane in green, photosensitiser in red, a merged image in yellow, and an orthogonal projection combining both colors. The arrangement highlights cellular localization and interaction of these compounds.</alt-text>
</graphic>
</fig>
<p>Fluorescence intensity profiles extracted from the confocal images (<xref ref-type="sec" rid="s10">Supplementary Figure S9</xref>) revealed peak intensities at the plasma membrane, consistent with dominant membrane accumulation. Intracellular puncta also displayed localized signals, suggesting vesicular internalization via endocytosis.</p>
</sec>
<sec sec-type="conclusion" id="s2">
<title>Conclusion</title>
<p>
<bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, two PSs with long excitation wavelengths and excellent singlet oxygen quantum yields (<inline-formula id="inf18">
<mml:math id="m18">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 610&#xa0;nm, <bold>[Ru-2ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, &#x3a6;<sub>&#x394;</sub> 77.2%, <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold>, &#x3a6;<sub>&#x394;</sub> 90.4%) were evaluated in cell toxicity studies on SKBR-3 cell lines. The cellular uptake of the compounds was minimal with both PSs residing in the plasma membrane. The dark toxicity of the compounds was significant, decreasing viability by 20% at concentrations of 50&#xa0;nM. The phototoxicity of the compounds (<inline-formula id="inf19">
<mml:math id="m19">
<mml:mrow>
<mml:mi>&#x3bb;</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>
<sub>ex</sub> 630&#xa0;nm, 33&#xa0;J&#xa0;cm<sup>&#x2212;2</sup>, 15&#xa0;min) led to circa 30% reduction in the viability for <bold>[Ru-2ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> and about 60% in the case of <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> at 10&#x2013;50&#xa0;nM concentrations. While the efficiency of the PSs is limited by their poor cellular uptake, <bold>[Ru-3ENR][(Cl)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> still shows good activity at the nanomolar region. The greater linearity of the coordinated 3ENR manifests a change in the degree of electronic delocalisation and the nature of the triplet excited state which is found to be situated across the entirety of the pyridyl-3ENR ligand. This improves the lifetime of the triplet excited state and <sup>1</sup>O<sub>2</sub> quantum yields as evidenced in similar systems in which the more linear framework shows photophysical improvements and is consistent with the previous computational evaluations (<xref ref-type="bibr" rid="B10">Lazic et al., 2017</xref>; <xref ref-type="bibr" rid="B18">Parella et al., 2024</xref>; <xref ref-type="bibr" rid="B4">Chamberlain et al., 2020</xref>).</p>
<p>Both photophysical measurements and theoretical calculations suggested that <bold>[Ru-3ENR][(PF</bold>
<sub>
<bold>6</bold>
</sub>
<bold>)</bold>
<sub>
<bold>2</bold>
</sub>
<bold>]</bold> would be a better performing PS, due to having higher &#x3a6;<sub>&#x394;</sub>, higher absorption and a higher rate constant of the intersystem crossing, k<sub>ISC</sub>. These predictions carried through into the <italic>in vitro</italic> cell studies however experimentally determining the influence of the solvent was important particularly due to the IL&#x2a; charge transfer nature of the excited state. In addition, the photophysical properties such as absorption, emission, and singlet oxygen quantum yields were found to change significantly and in some cases favourably upon anion exchange (from PF<sub>6</sub> to Cl). The suitability of PS in biological applications such as PDT is also determined by the dark toxicity and cellular uptake. We will direct further studies with a view to exploring analogue modifications of the above complex salts. These will include detailed analyses involving mitochondrial assays, the mechanism of cell death, and the quantification of ROS generation, as appropriate. The aim will be to target improvements in terms of their cellular uptake while retaining the very advantageous photophysical properties of the materials examined to date.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s3">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec sec-type="ethics-statement" id="s4">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s5">
<title>Author contributions</title>
<p>CC: Investigation, Conceptualization, Writing &#x2013; review and editing, Software, Methodology, Formal Analysis, Visualization, Data curation, Writing &#x2013; original draft. OC-B: Writing &#x2013; original draft, Formal Analysis, Visualization, Data curation, Investigation, Methodology, Writing &#x2013; review and editing. JF: Writing &#x2013; original draft, Formal Analysis, Visualization, Writing &#x2013; review and editing, Data curation. AA: Writing &#x2013; review and editing, Visualization. XX: Data curation, Methodology, Investigation, Software, Formal Analysis, Writing &#x2013; review and editing. JZ: Supervision, Writing &#x2013; review and editing, Resources. CN: Writing &#x2013; review and editing, Resources, Writing &#x2013; original draft, Visualization, Formal Analysis, Investigation, Supervision, Methodology. SD: Validation, Resources, Data curation, Conceptualization, Project administration, Formal Analysis, Investigation, Funding acquisition, Methodology, Writing &#x2013; review and editing, Supervision, Writing &#x2013; original draft.</p>
</sec>
<sec sec-type="funding-information" id="s6">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This publication has emanated from research conducted with the financial support of Science Foundation Ireland (Grant Number 15/IA/3046), and Research Ireland (Grant Number 12/RC/2278_2) which is co-funded under the European Regional Development Fund under the AMBER award. A.Al-R. acknowledges funding from a TCD Postgraduate Studentship 1252 Award. C.C., and J.F. acknowledge funding support from the Trinity Research Doctoral Higher Education Authority and the Department of Further and Higher Education, Research, Innovation and Science.</p>
</sec>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s8">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchbi.2025.1620562/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchbi.2025.1620562/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barretta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ponte</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scoditti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mazzone</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2024a</year>). <article-title>Computational assessment of novel ruthenium phenoxazine-based complexes as photosensitizers in photodynamic therapy</article-title>. <source>Eur. J. Inorg. Chem.</source> <volume>27</volume> (<issue>n/a</issue>), <fpage>e202400309</fpage>. <pub-id pub-id-type="doi">10.1002/ejic.202400309</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barretta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Scoditti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Belletto</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ponte</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vigna</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mazzone</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2024b</year>). <article-title>Ruthenium complexes bearing nile red chromophore and one of its derivative: theoretical evaluation of PDT-related properties</article-title>. <source>J. Comput. Chem.</source> <volume>45</volume> (<issue>23</issue>), <fpage>2034</fpage>&#x2013;<lpage>2041</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.27392</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabrera-Gonz&#xe1;lez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Soriano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Conway-Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Multinuclear Ru(ii) and Ir(iii) decorated tetraphenylporphyrins as efficient PDT agents</article-title>. <source>Biomaterials Sci.</source> <volume>7</volume> (<issue>8</issue>), <fpage>3287</fpage>&#x2013;<lpage>3296</lpage>. <pub-id pub-id-type="doi">10.1039/C9BM00192A</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Roque</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bellnier</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McFarland</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Shafirstein</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>TLD1433-Mediated photodynamic therapy with an optical surface applicator in the treatment of lung cancer cells <italic>in vitro</italic>
</article-title>. <source>Pharmaceuticals</source> <volume>13</volume> (<issue>7</issue>), <fpage>137</fpage>. <pub-id pub-id-type="doi">10.3390/ph13070137</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Condon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Conway-Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hallen</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Twamley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Exploring the dark: detecting long-lived nile red 3ILCT states in Ru(ii) polypyridyl photosensitisers</article-title>. <source>J. Mater. Chem. C</source> <volume>9</volume> (<issue>41</issue>), <fpage>14573</fpage>&#x2013;<lpage>14577</lpage>. <pub-id pub-id-type="doi">10.1039/D1TC02830H</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conway-Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ferrer-Ugalde</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Careta</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nogu&#xe9;s</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Ru(ii) and Ir(iii) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT</article-title>. <source>Biomaterials Sci.</source> <volume>9</volume> (<issue>16</issue>), <fpage>5691</fpage>&#x2013;<lpage>5702</lpage>. <pub-id pub-id-type="doi">10.1039/D1BM00730K</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Horan</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Twamley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McGarrigle</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Accessing unsymmetrical ru(ii) bipyridine complexes: a versatile synthetic mechanism for fine tuning photophysical properties</article-title>. <source>Chem. Commun.</source> <volume>59</volume> (<issue>3</issue>), <fpage>330</fpage>&#x2013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1039/D2CC04910D</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Blacque</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Malcomson</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Targeted photoredox catalysis in cancer cells</article-title>. <source>Nat. Chem.</source> <volume>11</volume> (<issue>11</issue>), <fpage>1041</fpage>&#x2013;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-019-0328-4</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Josefsen</surname>
<given-names>L. B.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>R. W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Photodynamic therapy and the development of metal-based photosensitisers</article-title>. <source>Metal-Based Drugs</source> <volume>2008</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1155/2008/276109</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kaspler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Monro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sainuddin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Forward</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Novel osmium-based coordination complexes as photosensitizers for panchromatic photodynamic therapy</article-title>. <source>Photochem. Photobiol.</source> <volume>93</volume> (<issue>5</issue>), <fpage>1248</fpage>&#x2013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1111/php.12767</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Caverly</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016a</year>). <article-title>Iridium(III) complexes bearing pyrene-functionalized 1,10-Phenanthroline ligands as highly efficient sensitizers for triplet-triplet annihilation upconversion</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>55</volume> (<issue>47</issue>), <fpage>14688</fpage>&#x2013;<lpage>14692</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201608442</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Twamley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Delaney</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016b</year>). <article-title>Highly efficient triplet photosensitizers: a systematic approach to the application of IrIII complexes containing extended phenanthrolines</article-title>. <source>Chem. &#x2013; A Eur. J.</source> <volume>22</volume> (<issue>32</issue>), <fpage>11349</fpage>&#x2013;<lpage>11356</lpage>. <pub-id pub-id-type="doi">10.1002/chem.201601534</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Conway&#x2010;Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Twamley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>1,10-Phenanthroline Ruthenium(II) complexes as model systems in the search for high-performing triplet photosensitisers: addressing ligand <italic>versus</italic> metal effects</article-title>. <source>ChemPhotoChem</source> <volume>1</volume> (<issue>12</issue>), <fpage>544</fpage>&#x2013;<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1002/cptc.201700158</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Conway-Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Exploiting coumarin-6 as ancillary ligands in 1,10-phenanthroline Ir(iii) complexes: generating triplet photosensitisers with high upconversion capabilities</article-title>. <source>Dalton Trans.</source> <volume>47</volume> (<issue>26</issue>), <fpage>8585</fpage>&#x2013;<lpage>8589</lpage>. <pub-id pub-id-type="doi">10.1039/C8DT00231B</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gandioso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vinck</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Notaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gourdon</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Structurally simple Osmium(II) polypyridyl complexes as photosensitizers for photodynamic therapy in the near infrared</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>62</volume> (<issue>20</issue>), <fpage>e202218347</fpage>. <pub-id pub-id-type="doi">10.1002/anie.202218347</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mital</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ziora</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Biological applications of Ru(II) polypyridyl complexes</article-title>. <source>Coord. Chem. Rev.</source> <volume>375</volume>, <fpage>434</fpage>&#x2013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2018.02.013</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Col&#xf3;n</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Roque</surname>
<given-names>J.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Konda</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gujar</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433</article-title>. <source>Chem. Rev.</source> <volume>119</volume> (<issue>2</issue>), <fpage>797</fpage>&#x2013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00211</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Blanquer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>H&#xfc;mpfner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hernando</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mora</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Developing photo-activable ruthenium (II) complexes for PDT: synthesis, characterization, photophysical and biological studies</article-title>. <source>Dyes Pigments</source> <volume>224</volume>, <fpage>111985</fpage>. <pub-id pub-id-type="doi">10.1016/j.dyepig.2024.111985</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McGoldrick</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Dual phosphorescent dinuclear transition metal complexes, and their application as triplet photosensitizers for TTA upconversion and photodynamic therapy</article-title>. <source>J. Mater. Chem. C</source> <volume>4</volume> (<issue>25</issue>), <fpage>6131</fpage>&#x2013;<lpage>6139</lpage>. <pub-id pub-id-type="doi">10.1039/C6TC01926A</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Conway-Kenny</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Twamley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Novel ruthenium and iridium complexes of N-substituted carbazole as triplet photosensitisers</article-title>. <source>Chem. Commun.</source> <volume>54</volume> (<issue>9</issue>), <fpage>1073</fpage>&#x2013;<lpage>1076</lpage>. <pub-id pub-id-type="doi">10.1039/C7CC08535D</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mesdom</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Purkait</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saubam&#xe9;a</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Burckel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Arnoux</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours</article-title>. <source>Chem. Sci.</source> <volume>14</volume> (<issue>42</issue>), <fpage>11749</fpage>&#x2013;<lpage>11760</lpage>. <pub-id pub-id-type="doi">10.1039/D3SC03932C</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>